Healthy Skepticism Library item: 3989

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

MaLAM letter follow up—Last gasps for a respiratory stimulant
MaLAM Newsletter 1989 Jan; 1

Abstract:

Ciba-Geigy has withdrawn some indications for nikethamide but the remaining ones are not supported by scientific literature.

Keywords:
*analysis/developing countries/nikethamide/Ciba-Geigy/children/company responses/MaLAM/Medical Lobby for Appropriate Marketing/quality of information/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/REGULATION, CODES, GUIDELINES: FEEDBACK TO COMPANIES